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Summary
Background Index-linked HIV testing, whereby children of individuals with HIV are targeted for testing, increases 
HIV yield but relies on uptake. Community-based testing might address barriers to testing access. In the Bridging the 
Gap in HIV testing and care for children in Zimbabwe (B-GAP) study, we investigated the uptake and yield 
of index-linked testing in children and the uptake of community-based vs facility-based HIV testing in Zimbabwe.
Methods B-GAP was an interventional study done in the city of Bulawayo and the province of Matabeleland South 
between Jan 29 and Dec 12, 2018. All HIV-positive attendees (index patients) at six urban and three rural primary 
health-care clinics were offered facility-based or community-based HIV testing for children (age 2–18 years) living in 
their households who had never been tested or had tested as HIV-negative more than 6 months ago. Community-based 
options involved testing in the home by either a trained lay worker with a blood-based rapid diagnostic test (used in 
facility-based testing), or by the child’s caregiver with an oral HIV test. Among consenting individuals, the primary 
outcome was testing uptake in terms of the proportion of eligible children tested. Secondary outcomes were uptake of 
the different HIV testing methods, HIV yield (proportion of eligible children who tested positive), and HIV prevalence 
(proportion of HIV-positive children among those tested). Logistic regression adjusting for within-index clustering 
was used to investigate index patient and child characteristics associated with testing uptake, and the uptake 
of community-based versus facility-based testing.
Findings Overall, 2870 index patients were linked with 6062 eligible children (3115 [51·4%] girls [sex unknown in 
seven], median age 8 years [IQR 5–13]). Testing was accepted by index patients for 5326 (87·9%) children, and 
3638 were tested with a known test outcome, giving an overall testing uptake among 6062 eligible children 
of 60·0%. 39 children tested positive for HIV, giving an HIV prevalence among the 3638 children of 1·1% and an 
HIV yield among 6062 eligible children of 0·6%. Uptake was positively associated with female sex in the index 
patient (adjusted odds ratio [aOR] 1·56 [95% CI 1·38–1·77], p<0·0001) and child (aOR 1·10 [1·03–1·19], p=0·0080), 
and negatively associated with any financial cost of travel to a clinic (aOR 0·86 [0·83–0·88], p<0·0001), increased 
child age (6–9 years: aOR 0·99 (0·89–1·09); 10–15 years: aOR 0·91 [0·83–1·00]; and 16–18 years: aOR 0·75 
[0·66–0·85]; p=0·0001 vs 2–5 years), and unknown HIV status of the mother (aOR 0·81 [0·68–0·98], p=0·027 
vs HIV-positive status). Additionally, children had increased odds of being tested if community-based testing was 
chosen over facility-based testing at screening (1320 [73·9%] children tested of 1787 vs 2318 [65·5%] of 3539; aOR 1·49 
[1·22–1·81], p=0·0001).
Interpretation The HIV yield of index-linked testing was low compared with blanket testing approaches in similar 
settings. Index-linked HIV testing can improve testing uptake among children, although strategies that improve 
testing uptake in older children are needed. Community based testing by lay workers is a feasible strategy that can be 
used to improve uptake of HTS among children and adolescents.
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The scale-up of antiretroviral therapy (ART) globally in 
the past 20 years has substantially reduced HIV-
associated mortality across all age groups.1 However, 
glo bally the cov erage of ART in children (<15 years) was 
only 53% in 2019, largely due to delays in diagnosis.2 
Testing of HIV-exposed children within pre vention 
of mother-to-child trans mission (PMTCT) pro grammes 
remains sub optimal, and subsequently children with 
perinatally acq uired HIV are often diagnosed later 
in childhood when they present with HIV-associated 
seque lae.3,4 Late diag nosis is associated with chronic 
com pli cations such as growth failure, organ damage, 
and increased mortality.5–7 Effective strategies to address 
the barriers to HIV diagnosis in children are urgently 
needed.8
Articles
2 www.thelancet.com/hiv   Published online November 13, 2020   https://doi.org/10.1016/S2352-3018(20)30267-8
Given the relatively low prevalence of HIV in children,2,3 
targeted HIV testing strategies, including the use of 
screening tools and index-linked testing, have been 
suggested to improve testing efficiency and potentially 
reduce costs.9 Index-linked testing, whereby an HIV test 
is offered to contacts of an index case (ie, an individual 
living with HIV), has been shown to increase HIV yield 
when used in children, but as with any other testing 
strategy, it relies on uptake by parents and carers.9,10 The 
test location (eg, health facilities vs community-based 
settings) might influence uptake.11 Barriers to facility-
based testing in children include inflexible facility 
working hours, user fees, distance to clinics, transport 
costs, and insufficient or overworked health-care pro-
viders.12 In view of these barriers, WHO recommended 
the use of lay workers in community settings in 2018 to 
reduce costs and increase uptake of HIV testing services 
(HTS).13 Index-linked testing of children, adolescents, 
and young adults (age 1–24 years) in community-based 
settings resulted in higher uptake than at health facilities 
in Malawi.14 In recent years, self-testing with oral mucosal 
transudate (OMT) has been implemented among adults 
in sub-Saharan Africa,15,16 and an extension of this 
approach whereby caregivers test their children might 
also improve accessibility.17 Offering indexes a choice 
of different HTS delivery models acknowledges different 
preferences, and providing flexi bility in the place and 
mode of HTS delivery might optimise uptake of index-
linked HIV testing.
Zimbabwe has an early-onset, sustained, severe 
HIV epi demic, with an adult HIV prevalence of 13% 
in 2018.3 HIV prevalence in child ren (age 0–14 years) 
was 1·6% and in young people (age 15–24 years) was 4·4% 
in 2016.3,18 Although PMTCT coverage in Zimbabwe is 
high, with 94% of HIV-positive pregnant women receiving 
ART, only 63% of infants born to HIV-positive mothers 
were tested within the first 2 months of birth in 2019.3
In the Bridging the Gap in HIV testing and care for 
chil dren in Zimbabwe (B-GAP) study, we evaluated 
index-linked testing provided in health facilities and via 
two community-based approaches (namely testing by a 
trained lay worker and HIV testing by the caregiver at 
home using OMT), for children aged 2–18 years in rural 
and urban Zimbabwe. The aim of this study was to 
investigate the uptake and yield of index-linked testing 
and factors associated with its acceptance. We also 
investigated the choice of testing methods (ie, com-
munity-based vs facility-based testing) and factors 
associated with acceptance of community-based over 
facility-based index-linked HIV testing. We hypothesised 
that offering HTS to chil dren living in households with 
an HIV-positive individual will result in a high yield 
Research in context
Evidence before this study
HIV testing rates in children exposed to HIV remains low 
in prevention of mother-to-child transmission programmes 
in sub-Saharan Africa, with many children being diagnosed 
late in childhood when they develop advanced disease. Due 
to the relatively low HIV prevalence among children and 
adolescents, targeted HIV testing services (HTS) approaches 
such as index-linked testing (HIV testing offered to children in 
the same household as people with HIV) might be most efficient 
and cost-effective. On April 1, 2020, we searched Medline for 
studies on index-linked HIV testing in children and adolescents, 
without restrictions on date, location, or language. Using the 
keywords “HIV testing”, “index”, “children”, and “adolescents”, 
we found five studies that had evaluated index-linked testing 
in children and adolescents (age 0–19 years). The studies were 
done in Cameroon, Kenya, Lesotho, and Malawi between 
2016 and 2019. All of the studies reported higher HIV yield with 
index-linked testing than that obtained via routine HTS. Only 
one of the studies offered index-linked HIV testing in both rural 
and urban settings and only two studies offered index patients 
a choice of test location (facility-based or community-based). 
None of the five studies evaluated factors associated with 
uptake of testing.
Added value of this study
Our study is the first to compare the uptake of index-linked 
testing in children via health facility testing versus 
community-based testing by lay workers or caregivers in 
an HIV-prevalent setting. We evaluated preferred choice 
of HIV testing modality, and index patient and child factors 
associated with choice and uptake of testing. Our study shows 
that, although facility-based methods are more commonly 
chosen when initially proposed, probably because this 
approach is well known to the public, actual uptake of 
HTS is higher with community-based approaches. 
Community-based approaches might address some of the 
key barriers to facility-based testing, such as travel costs, 
distance to a clinic, particularly in rural areas, and suboptimal 
access due to restrictive opening hours of health facilities. 
Our study also shows that community HTS provided by lay 
workers and caregivers is feasible.
Implications of all the available evidence
To reach the UNAIDS 95-95-95 targets (95% of HIV-positive 
people aware of status, ART for 95% of those diagnosed, 
and viral suppression for 95% of those treated by 2030), 
HTS strategies will need to focus on hard-to-reach populations 
and address barriers that existing approaches have not been 
able to overcome. Community-based approaches might 
address such barriers but will require sensitisation and 
education of communities, and support for caregivers who 
test their children. Quality control, monitoring, and linkage 
to care for children who test positive will need to accompany 
these approaches.
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of HIV diagnoses when compared with approaches that 
are not targeted, and that the option for community-
based HTS might increase uptake compared with 
facility-based HTS alone.
Methods
Study design and participants
The B-GAP study was an interventional study without a 
control group done in Bulawayo, the second largest city 
in Zimbabwe, and Matabeleland South province, between 
Jan 29 and Dec 12, 2018. Matabeleland South borders 
Botswana and has the highest HIV prevalence (20·4%) 
in the country.18 Three rural primary health-care clinics in 
Mangwe district in Matabeleland South and six urban 
primary health-care clinics in Bulawayo were purposively 
selected on the basis of the number of patients registered 
for HIV care and distance to another facility.18
At each facility, all individuals attending for HIV care, 
regardless of ART status and time since diagnosis, were 
screened over 3 months to identify index cases. The 
national HIV programme provides a 3 month drug 
supply, therefore the majority of clinic attendees were 
anticipated to have undergone eligibility screening for 
study inclusion by 3 months. After screening and inclu-
sion, a structured questionnaire collecting socio demo-
graphic data, the number of children in the house hold, 
and their HIV status was administered by research 
assistants to index patients and data was entered on 
electronic tablets into Open Data Kit (version 1.11.1). 
Index patients were defined as con senting HIV-positive 
individuals who had at least one child aged 2–18 years 
living in their household (regardless of whether or not 
they were a biological parent) who was eligible for HTS 
(ie, had never had an HIV test or had a negative HIV test 
more than 6 months before screening). Children who 
were reported to have had an HIV-negative test more 
than 6 months ago were eligible for testing as index 
patients could have over-reported testing of children, 
older adolescents might have been sexually active, and 
some children might have been victims of sexual abuse.
Written informed consent for participating in the study 
was obtained from all eligible index patients in either 
English, Shona, or Ndebele when they were approached 
at the health facility. Index individuals aged younger than 
18 years were included in the study if accompanied by an 
adult who could provide consent. At the point of testing 
of children either at the facility or in the community, 
verbal consent from the child’s parent or legal guardian 
and child assent (for children aged <16 years) or direct 
verbal consent from the child (for children aged ≥16 years) 
for HIV testing was sought.
Ethical approval for this study was obtained from the 
Medical Research Council of Zimbabwe, the institutional 
review board of the Bio medical Research and Training 
Institute of Zimbabwe, and the London School of 
Hygiene & Tropical Medicine ethics committee. The 
B-GAP study protocol has been published previously.19
Procedures
Index patients were offered three choices of HIV testing 
for eligible children living in their household: testing in 
the health facility; testing by a lay worker at home; or 
testing by the index caregiver at home. Testing in the 
facility was done by routine clinic staff or research 
assistants. Research assistants were the lay workers and 
in addition to training for the study had undergone 
a 2-week training course on rapid HIV testing and coun-
selling provided by a private training institution affiliated 
with the Zimbabwe Ministry of Health and Child Care. 
The lay workers were stationed at each clinic. Index 
patients could only elect for caregiver testing if they were 
a biological parent or the legal guardian to ensure 
safeguarding of children who would be tested in the 
absence of a health-care provider. Caregiver testing was 
done with OMT (OraQuick ADVANCE Rapid HIV-1/2; 
OraSure Technologies, Bethlehem, PA, USA). Caregivers 
were counselled and shown how to do the test by research 
assistants at each facility. If assessed by the research 
assistant to be competent to test, they were given an 
OMT HIV test for each eligible child and asked to do the 
test within 5 days. A helpline number for counselling 
and support was provided. Results of caregiver-provided 
testing were by self-report. Index patients who chose 
caregiver-pro vided testing were told to return to the 
facility for confirmatory HIV testing in the event of 
a reactive OMT test as per WHO guidelines.20
Index patients who chose community testing by a lay 
worker were visited at home on a scheduled date. Up to 
two further home visits were undertaken if the child was 
not present on the scheduled date. For facility and 
caregiver-provided testing, all index patients were con-
tacted by lay workers by phone on days 7, 14, and 21 post-
screening if their children had not yet been tested. If 
unreachable by phone, a maximum of two home visits 
were undertaken and HIV testing done at home by a lay 
worker if the index patient and child consented. There-
fore, index patients who initially chose facility-based 
testing could later consent to testing in the home. Simi-
larly, index patients who initially chose community-based 
testing could, at a later date, switch to testing at the 
facility. The test method chosen by the index patient at 
screening and the final test location for children was 
recorded. Testing at the facility or community-based 
testing by a lay worker was done according to the national 
HIV testing algorithm via a blood-based rapid diagnostic 
test, with results available on the same day.21 We defined 
community-based testing as either testing done by a lay 
worker at home or caregiver-provided testing.
Children were given age-appropriate explanations 
of the test results, determined by the age and maturity of 
the child and guided by the Zimbabwe Ministry of Health 
and Child Care guidelines for HIV testing and coun-
selling for children.22
For children who were not tested, the reason was 
recorded. Children who tested HIV-positive were referred 
Articles
4 www.thelancet.com/hiv   Published online November 13, 2020   https://doi.org/10.1016/S2352-3018(20)30267-8
to their nearest facility or the preferred facility of the 
child or household for onward care.
Outcomes
The primary outcome of the study was the uptake 
of testing, defined as the proportion of eligible children 
having an HIV test during the study. Secondary outcomes 
were the uptake of the different HIV testing methods, 
HIV yield, and HIV prevalence. HIV yield was defined as 
the proportion of HIV-positive children among all eli gible 
children. HIV prevalence was defined as the proportion of 
HIV-positive children among those tested. Any children 
with an unknown test outcome were classed as not tested 
and therefore not included in the denominator for HIV 
prevalence.
Statistical analysis
Sample size estimations were based on precision of the 
estimated proportion taking up HIV testing. An average 
of 32 clients were anticipated to attend a clinic per day. 
A sample size of 6739 children would provide a 1% pre-
cision interval for an estimate of 80% of children taking 
up testing. An average of 32 clients were anticipated to 
attend a clinic per day based on routine data on attendance 
of each clinic in 2017. Therefore, during the 3 month study 
period at each clinic, in nine clinics assuming 5 working 
days per week, this visit rate would provide sufficient 
numbers of index patients assuming 30–40% of index 
patients had eligible children and accepted participation. 
Within-index clus tering was not taken into account when 
calculating sample size due to the small numbers of 
children expected in each household.
All analyses were done with Stata software (version 15.0). 
Continuous variables were summarised as means and 
SDs or medians and IQRs, and categorical variables as 
counts and percentages. We used univariable logistic 
regression to investigate the association bet ween index 
patient characteristics and at least one child in their 
household having an HIV test, and between child charac-
teristics and a child having an HIV test. Index charac-
teristics of interest were age, sex, health-care facility 
setting (rural or urban), highest level of education, time 
since HIV diagnosis, mode of transport to the facility, and 
cost of travel to the facility. Child charac teristics of interest 
were age, sex, HIV status, relationship to index patient, 
orphanhood status, mother’s HIV status, history of 
receiving ART for PMTCT, and any previous offer of 
HIV testing. For each model, significant index patient or 
child variables (at p<0·10) in univariable analysis were 
retained in multivariable logistic regression models 
(significance deemed at p<0·10). Using logistic regression 
we also evaluated the odds of having an HIV test by 
selected testing model adjusted for clustering by index. 
For models including child characteristics, robust stan-
dard errors or generalised estimating equations were 
used to allow for household-level clustering. Additionally, 
index patient and child characteristics associated with 
selection of community-based testing models versus 
facility-based testing at screening were evaluated in uni-
var iable and multivariable models. As sensitivity analyses, 
we investi gated factors associated with selection of testing 
by a lay worker versus facility-based testing, and with 
selection of testing provided by a caregiver versus facility-
based testing. Clustering by index patient was adjusted 
for in all models including child variables. An independent 
project steering committee met annually.
Role of the funding source
The funders of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to all 
the data in the study and had final responsibility for the 
decision to submit for publication.
Results
Between Jan 29 and Dec 12, 2018, 9927 individuals were 
screened in the nine primary health-care clinics 
(427–2005 per clinic), of whom 5164 reported no children 
aged 2–18 years in the household and 820 declined 
consent to provide information about children in their 
household. Of the remaining 3943 individuals, 2870 had 
at least one child eligible for HTS in their household and 
were therefore classed as index patients (figure 1). The 
median age of index patients was 39 years (IQR 32–46) 
and 2259 (78·8% of 2866 with available data) were 
women. 1622 (56·5%) of the 2870 index patients had 
been diagnosed with HIV in the past 5 years. The main 
means of transport to the clinic was by foot (for 
1874 [65·4%] of 2866 with available data; table 1). The 
median number of children living in the households of 
index patients was 1 (IQR 1–3).
8218 children (4147 [50·5%] girls [sex unknown in 
nine], median age 9 years [IQR 5–13]) living in the 
households of index patients (n=3943) were screened for 
eligibility (figure 1). Of these children, 6062 (73·8%) were 
eligible for index-linked testing (3115 [51·4%] girls [sex 
unknown in seven], median age 8 years [IQR 5–13]), with 
2837 (34·5%) having tested HIV-negative more than 
6 months ago, and 3225 (39·2%) having not previously 
tested. The range in eligibility prevalence by clinic 
was 54·4–98·6%. 500 (6·1%) children had a known 
HIV-positive status.
Of the 2870 index patients with at least one eligible child, 
1789 (62·3%) had at least one child in their household 
tested, including 1012 (35·3%) who had two or more 
children tested. Overall, 1476 (51·4%) index patients had all 
eligible child ren in their households tested. In terms of 
corresponding numbers in children, HIV testing was 
accepted for 5326 (87·9%) of 6062 eligible children (range 
by clinic 61·3–98·4%). The main reason for index patients 
refusing testing in 736 children was that the index patient 
was not the biological parent of the eligible child (304 
[41·3%] children). In the 5326 children with acceptance for 
testing, 3638 (68·3%) were subsequently tested (range by 
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clinic 53·5–92·0%), representing an overall uptake of HTS 
among 6062 eligible children of 60·0% (figure 1). Among 
1688 children not tested despite acceptance by the index 
patient, the main reasons for non-uptake were inability to 
contact chil dren (1101 [65·2%]) and no consent from 
guardians at the point of testing (161 [9·5%]).
Of the 3638 children with an HIV test outcome, 39 were 
positive, giving an HIV prevalence of 1·1%, and an HIV 
yield among 6062 eligible children of 0·6%. HIV 
prevalence was 1·0% (24 of 2322 children) in urban 
settings and 1·1% (15 of 1316) in rural settings. The 
median age of children diagnosed with HIV was 11 years 
(IQR 8–15; range 3–18) and 28 (71·8%) were girls. 
17 (43·6%) of the 39 children were single or double orp-
haned, 25 (64·1%) were biological children of the index 
patient, 28 (71·8%) had not been previously tested, and 
nine (23·1%) were linked to index patients who had been 
diagnosed within the past year. HIV was diagnosed in 
26 (prevalence 1·4%) of 1916 children tested in a health-
care facility and 13 (0·8%) of 1722 children tested in the 
community. In the com munity, HIV was diagnosed in 
12 (0·8%) of 1522 children tested by a lay worker, and one 
(0·5%) of 200 tested by their caregiver using OMT and 
confirmed HIV-positive at their health-care facility. Of 
the 39 children who tested HIV-posi tive and received 
a referral, 36 (92·3%) were registered with a facility.
The proportion of index patients who had at least one 
child tested was similar between urban (1286 [61·7%] of 
2084 index patients) and rural (504 [64·1%] of 786) sites 
(table 1). In our univariable analysis of index patient 
characteristics, female sex, cost to travel to the facility, and 
mode of transport were associated with HIV testing for at 
least one child in the household. In multivariable analysis, 
female sex of the index patient was associated with at least 
Figure 1: Screening and HIV testing flow for HIV-positive clinic attendees (green) and children living in their households (blue)
HTS=HIV testing services. *490 children registered in care and 10 not registered in care. †Test result slip or note in the child’s medical records.
9927 patients screened 
4763 with children (age 2–18 years) 
in the household
5164 without children in the household
3943 eligible patients with children 
in the household and consented 
to provide information about 
household 
820 declined consent 
2870 patients (index) living with 
at least one eligible child 
1073 without children eligible for testing
8218 children living in household
with eligible index patient
6062 children eligible for HTS
2837 HIV-negative >6 months
3225 not previously tested
2156 children ineligible for HTS
 500 HIV-positive*
 1656 HIV-negative <6 months
1081 without testing of children 
in the household
1789 index patients with at least one 
eligible child tested 
736 children for whom testing was 
refused by index patient
 304 not biological child of the 
index patient
 203 for whom testing not wanted
 47 for whom index did not have 
time for testing
 182 with other reasons
5326 eligible children whose index 
patient accepted testing
1688 children not tested
 1101 not found during tracing
 161 without parent or legal 
guardian consent 
 58 did not give assent
 31 with evidence† of a negative 
test within <6 months
 318 with other reasons
 19 with unknown test outcome
3638 children tested 
1751 index patients with children 
testing HIV-negative 
38 index patients with at least one 
child testing HIV-positive
39 children tested HIV-positive 3599 children tested HIV-negative
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one child in the household having an HIV test (adjusted 
odds ratio [aOR] 1·56 [95% CI 1·38–1·77], p<0·0001). 
Additionally, children were less likely to be tested if the 
index patient reported any financial cost for them to travel 
to the facility (aOR 0·86 [0·83–0·88], p<0·0001; table 1).
In our univariable analysis of child characteristics, 
having an HIV test was associated with sex, age, HIV 
status, relationship to the index patient, and mother’s 
HIV status. In multivariable analysis, female sex of the 
child was associated with having an HIV test (aOR 1·10 
[95% CI 1·03–1·19], p=0·0080). Increased age of the 
child (6–9 years: aOR 0·99 (0·89–1·09); 10–15 years: 
aOR 0·91 [0·83–1·00]; and 16–18 years: aOR 0·75 
[0·66–0·85]; p=0·0001 vs 2–5 years) and unknown 
HIV status of the mother (aOR 0·81 [0·68–0·98], 
p=0·027 vs HIV-positive status) were associated with 
reduced odds of having an HIV test (table 2).
Of the 5326 eligible children whose index patient 
accepted testing at screening, facility-based testing was 
chosen for 3539 (66·4%) children and community-based 
testing for 1787 (33·6%; figure 2). Per clinic, the pro portion 
of children whose index patients opted for community-
based testing ranged from 8·9% to 81·1%. In univariable 
analysis adjusting for clustering by index patient, the odds 
of the child being tested were higher if the index patient 
selected community-based testing versus facility-based 
testing (1320 [73·9%] children tested of 1787 vs 2318 [65·5%] 
of 3539; aOR 1·49 [95% CI 1·22–1·81], p=0·0001).
Regardless of initial choice, similar proportions of 
eligible children were tested by facility-based and 
community-based approaches (of 3638 children with a 
known test outcome overall, 1916 [52·7%] were tested at 
a facility vs 1722 [47·3%] in the community). 2318 children 
with ini tial acceptance for facility-based testing went on 
Index patient population Univariable analysis Multivariable analysis*
Patients with at least 
one eligible child 
(n=2870), n (%)
Patients with at least one child 
tested (n=1789), n (% of those 
with ≥1 eligible child)
OR (95% CI) p value aOR (95% CI) p value
Age, years
0–18 54 (1·9%) 36 (66·7%) 1·00 (ref) ·· ·· ··
19–34 892 (31·1%) 566 (63·5%) 0·87 (0·49–1·55) ·· ·· ··
35–59 1767 (61·6%) 1087 (61·5%) 0·80 (0·45–1·42) ·· ·· ··
≥60 157 (5·5%) 101 (64·3%) 0·90 (0·47–1·73) 0·63 ·· ··
Sex†
Male 607 (21·2%) 329 (54·2%) 1·00 (ref) ·· 1·00 (ref) ··
Female 2259 (78·8%) 1456 (64·5%) 1·53 (1·28–1·84) <0·0001 1·56 (1·38–1·77) <0·0001
Site
Rural 786 (27·4%) 504 (64·1%) 1·00 (ref) ·· ·· ··
Urban 2084 (72·6%) 1286 (61·7%) 0·90 (0·76–1·07) 0·24 ·· ··
Highest level of education completed†
None 45 (1·6%) 27 (60·0%) 1·00 (ref) ·· ·· ··
Primary 909 (31·7%) 571 (62·8%) 1·13 (0·61–2·08) ·· ·· ··
Secondary 1817 (63·4%) 1136 (62·5%) 1·11 (0·61–2·03) ·· ·· ··
Tertiary 95 (3·3%) 52 (54·7%) 0·77 (0·38–1·59) 0·36 ·· ··
Mode of transport to facility†‡
By foot 1874 (65·4%) 1259 (67·2%) 1·00 (ref) ·· ·· ··
Public transport 844 (29·4%) 442 (52·4%) 0·54 (0·46–0·64) <0·0001 ·· ··
By car 42 (1·5%) 20 (47·6%) 0·45 (0·24–0·82) 0·0097 ·· ··
Other 106 (3·7%) 65 (61·3%) 0·78 (0·52–1·16) 0·22 ·· ··
Cost of travel to facility‡
No cost (0 US$) 1998 (69·6%) 1332 (66·7%) 1·00 (ref) ·· 1·00 (ref) ··
Some cost (>0 US$) 872 (30·4%) 458 (52·5%) 0·86 (0·83–0·90) <0·0001 0·86 (0·83–0·88) <0·0001
Time since HIV diagnosis, years§
<1 290 (10·2%) 174 (60·0%) 1·00 (ref) ·· ·· ··
1–5 1332 (46·6%) 820 (61·6%) 1·06 (0·82–1·38) ·· ·· ··
6–10 990 (34·7%) 618 (62·4%) 1·10 (0·85–1·45) ·· ·· ··
>10 245 (8·6%) 168 (68·6%) 1·45 (1·02–2·08) 0·16 ·· ··
Tested children were classed as all those who received a test and had a known test outcome. OR=odds ratio. aOR=adjusted OR. *Significant index patient variables (at p <0·10) 
in univariable analysis were retained in multivariable logistic regression. †Missing data for four index patients. ‡Only cost of travel to facility included in multivariate analysis 
due to collinearity with mode of transport to facility. §Missing data for 13 index patients.
Table 1: Index patient characteristics associated with HIV testing in at least one child
Articles
www.thelancet.com/hiv   Published online November 13, 2020   https://doi.org/10.1016/S2352-3018(20)30267-8 7
to be tested, 473 (20·4%) of whom were tested in the 
com munity. By contrast, 1320 children with acceptance 
for community-based testing went on to be tested, of 
whom 71 (5·4%) were tested in a facility (figure 2).
In univariate analysis adjusted for clustering by index, 
factors associated with uptake of community-based HIV 
testing were site type (urban or rural), index patient age, 
cost of travel to a facility, time since diagnosis in the 
index patient, child age, child HIV status, PMTCT treat-
ment history, and a previous offer of HIV testing. On 
multivariable analysis, urban residence (aOR 2·29 [95% 
CI 1·80–2·91], p<0·0001), any travel cost to the facility 
(aOR 1·21 [1·15–1·28], p<0·0001), and time since HIV 
diagnosis in the index patient (1–5 years since diagnosis: 
aOR 1·58 [1·07–2·31]; and ≥6 years since diagnosis, 
aOR 1·59 [1·07–2·35]; p=0·070 vs diagnosis <1 year ago) 
were associated with selection of community-based 
testing compared with facility-based testing at screening 
(table 3). Increased child age (6–9 years: aOR 1·20 
[1·02–1·41]; and 10–15 years: aOR 1·35 [1·14–1·59]; 
p=0·0020 vs 2–5 years) and unknown HIV status in the 
child (aOR 1·33 [1·12–1·59], p=0·0013) were also 
associated with selection of community-based testing at 
screening. Results were similar in our sensitivity analysis, 
in which the outcome was defined as testing delivered by 
a community lay worker (n=1487 children) compared with 




(n=3638), n (% of those 
eligible)
aOR (95% CI) p value aOR (95% CI) p value
Sex‡
Male 2940 (48·6%) 1720 (58·5%) 1·00 (ref) ·· 1·00 (ref) ··
Female 3115 (51·4%) 1911 (61·3%) 1·07 (1·01–1·15) 0·032 1·10 (1·03–1·19) 0·0080
Age, years‡
2–5 1801 (29·7%) 1159 (64·4%) 1·00 (ref) ·· 1·00 (ref) ··
6–9 1586 (26·2%) 956 (60·3%) 0·97 (0·89–1·06) ·· 0·99 (0·89–1·09)
10–15 1981 (32·7%) 1174 (59·3%) 0·89 (0·82–0·97) ·· 0·91 (0·83–1·00)
16–18 687 (11·3%) 342 (49·8%) 0·73 (0·65–0·82) <0·0001 0·75 (0·66–0·85) 0·0001
HIV status§
Never tested 3224 (53·2%) 1930 (59·9%) 1·00 (ref) ·· 1·00 (ref) ··
Known negative 
>6 months
2837 (46·8%) 1708 (60·2%) 1·10 (1·02–1·20) 0·021 1·06 (0·96–1·17) 0·28
Relationship to index patient‡
Non-biological child 2482 (41·0%) 1466 (59·1%) 1·00 (ref) ·· 1·00 (ref) ··
Biological child 3573 (59·0%) 2165 (60·6%) 1·22 (1·11–1·33) <0·0001 1·12 (0·96–1·32) 0·16
Orphanhood status‡
Not orphaned 4728 (78·1%) 2796 (59·1%) 1·00 (ref) ·· ·· ··
Paternal orphan 960 (15·9%) 613 (63·9%) 1·00 (0·90–1·12) 0·98 ·· ··
Maternal orphan 190 (3·1%) 101 (53·2%) 0·98 (0·79–1·23) 0·88 ·· ··
Double orphan 177 (2·9%) 121 (68·4%) 1·15 (0·91–1·46) 0·23 ·· ··
Mother’s HIV status¶
HIV-positive 3223 (63·9%) 2048 (63·5%) 1·00 (ref) ·· 1·00 (ref) ··
HIV-negative 901 (17·9%) 585 (64·9%) 0·83 (0·74–0·94) 0·0037 0·90 (0·76–1·07) 0·24
Unknown to index patient 920 (18·2%) 475 (51·6%) 0·73 (0·64–0·83) <0·0001 0·81 (0·68–0·98) 0·027
Prevention of mother-to-child transmission treatment history||
No 1839 (55·4%) 1147 (62·4%) 1·00 (ref) ·· ·· ··
Yes 1284 (38·7%) 758 (59·0%) 1·07 (0·97–1·18) 0·20 ·· ··
Unknown to index patient 196 (5·9%) 115 (58·7%) 1·05 (0·83–1·33) 0·67 ·· ··
Previous offer for HIV testing||
No 1191 (35·9%) 715 (60·0%) 1·00 (ref) ·· ·· ··
Yes 1999 (60·2%) 1216 (60·8%) 1·05 (0·95–1·17) 0·36 ·· ··
Unknown to index patient 136 (4·1%) 96 (70·6%) 1·10 (0·82–1·49) 0·52 ·· ··
Tested children were classed as all those who received a test and had a known test outcome. aOR=adjusted odds ratio (with adjustment for clustering by index patient). 
*Logistic regression with generalised estimating equations. †Significant child variables (at p <0·10) in univariable analysis were retained in multivariable logistic regression; 
n reflects children tested minus those with data missing on model variables. ‡Missing data for seven children. §Missing data for one child. ¶Missing data for 1018 children 
as question was introduced into the study after March 1, 2018. ||Question only asked if the child was the biological child of the index patient (n=3319).
Table 2: Child characteristics associated with having an HIV test
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facility-based testing (appendix pp 1, 2). Selection of 
caregiver-provided testing (n=300 chil dren) versus facility-
based testing at screening was associated with urban 
residence, the cost of transport, unknown HIV status 
in the child, and, additionally, female sex of the index 
patient (appendix pp 3, 4). No adverse events were reported 
in our study.
Discussion
We found an overall uptake of index-linked HIV testing 
of 60% after offering index patients a choice of 
facility-based or community-based HTS. A greater 
proportion of index patients chose facility-based testing 
over community-based testing; however, children were 
more likely to be tested if the index chose community-
based testing. Index patients who had to pay to get to the 
clinic were less likely to have children in their households 
tested, and older children were less likely to be tested. 
Some index patients refused testing for children because 
they were not the biological parents of children living in 
their households. This finding high lights the challenges 
of identifying children with HIV, who are dispro por-
tionately likely to be orphaned.23 Although being a bio-
logical child was associated with having a test in 
uni variable analysis, this effect was not significant in 
multivariate analysis. We also found that female index 
patients were more likely to have at least one child tested 
and female children were more likely to be tested than 
their male counterparts. Poor health-seeking behaviour 
is commonly reported among men and our study 
highlights the need for further work to engage men, to 
inform the development of acceptable HTS.24
The yield of HIV was lower than anticipated when 
compared with blanket approaches such as outpatient 
and inpatient provider-initiated testing and counselling 
in Zimbabwe and within sub-Saharan Africa, in which 
HIV yield among children and adolescents ranged from 
7·4% to 12·2%.11 This finding might be due to the scale-
up of the PMTCT programme in Zimbabwe, where 
coverage was 94% in 2018.3,25 Although index-linked 
testing implemented in Kenya and Malawi detected high 
prevalence of HIV (7·4% among children aged <12 years 
in Kenya and 4·0% among individuals aged 1–24 years in 
Malawi), their PMTCT coverage was similar at 91% and 
95%, indicating the possibility of missed diagnoses 
before the scale-up of PMTCT.3,14,26 Alternatively, low yield 
could also imply that even index-linked HTS is an 
insufficient strategy to address the gap in HIV testing for 
children in Zimbabwe. Some index patients refused 
testing or did not complete testing for eligible children in 
their house holds. Further studies evaluating reasons or 
risk factors for non-uptake of testing are therefore 
warranted. How ever, we do note that while 500 children 
living in households with an index patient were known to 
be HIV-positive before the study, 39 (7·2%) of 
539 children (500 who were known HI-positive and 
39 newly diagnosed in this study) had been missed by 
existing services.
The median age of children diagnosed with HIV in our 
study was 11 years. Older children are at particularly high 
risk of living with undiagnosed HIV as they have missed 
HIV testing within PMTCT programmes27 and were less 
likely to be tested in our study. A misplaced assumption 
might be that an older child who is not ill is unlikely to 
have perinatally acquired HIV infection, particularly 
when the mother’s status is not known. In addition, 
adolescents are a challenging group to engage within 
health services. In our study, older children and children 
whose mother’s HIV status was not known had lower 
odds of being tested. Our findings highlight the need for 
continued efforts to expand HTS particularly among 
older adolescents. Notably, this age group is also at risk of 
horizontal transmission and index-linked testing might 
need to be combined with other approaches.
Facility-based index-linked testing has been recom-
mended in WHO guidelines and in Zimbabwean 
national guidelines.19,28 Our study found that similar 
pro portions of children were tested by facility-based or 
community-based index-linked HIV testing, despite 
substantially more index patients choosing facility-
based testing at screening. Community-based testing 
poten tially addresses some of the barriers to HTS, such 
as costs of travel to health facilities and the time taken 
Figure 2: Selection of facility-based (blue) and community-based (green) HIV testing for eligible children 
whose index patient accepted testing
*1487 children with acceptance for testing by a lay worker and 300 for testing by a caregiver at screening.
1522 tested by community lay
worker
 1026 with acceptance for 
community lay worker testing
 26 switched from caregiver- 
provided testing
470 switched from facility-based 
testing 




3539 children with acceptance for
facility-based testing 
2318 tested
1916 tested at facility
 1845 originally on facility-based 
testing
 10 switched from 
caregiver-provided testing
 61 switched from 
community lay worker 
testing
1722 tested in the community
 1249 originally on 
community-based testing
 473 originally on facility-based 
testing
1221 not tested
200 tested by caregiver
 197 with acceptance for 
caregiver-provided testing
 3 switched from facility-based 
testing 
See Online for appendix
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by index patients to bring children to facilities. Children 
were less likely to be tested if the index patient had to 
pay for travel (eg, via public transport or a car) rather 
than walk to a health facility. In addition, paying for 
travel to a health facility was associated with selection of 
community-based rather than facility-based HIV testing 
by the index patient. Community-based index-linked 
testing might identify children who are particularly 
hard to reach with currently available approaches. 
Indeed, index patients who had been diag nosed with 
HIV for a long period of time, increased age of the child, 
and no history of previous testing of the child, all of 
which are indicators of a lack of engagement with HTS 
for children, were independently associated with selec-
tion of community-based HIV testing.
Although WHO has recommended community-based 
HIV testing by lay workers,13 in many countries including 
Zimbabwe, HTS in the community is done by nurses. In 
the B-GAP study, lay workers underwent 2 weeks of 
training on study processes and rapid HIV testing and 
caregivers were also able to test their children using an 
oral HIV test after brief demon strations within the health 
facility. Our study shows the feasibility of lay individuals 
with minimal training implementing community-based 
HTS. HIV self-testing for adults has had high uptake 
among groups such as men, older adolescents (age 
16–18 years), sex workers, and men who have sex with 
men.13,15,16 This high uptake is often attributed to ease, 
privacy, and confi dentiality, and the non-invasiveness of 
the test compared with blood-based testing.13,15,29 We 
identified a low uptake of caregiver-provided testing, 
probably due to poor awareness of self-testing among our 
study population, for whom HIV self-testing is not yet 
routinely or widely available. In our study, female index 
patients were more likely to take up caregiver-provided 
testing, which might reflect the potential useful ness of 
this strategy within PMTCT programmes.
Community-based testing by lay workers or caregivers 
could reduce workload for facility-based health workers 
and has potential to be cost-effective.30 Additionally, 
community-based testing could be used as a back-up 
mechanism for children who do not present for facility-
based index-linked testing. Many children in our study 
were subsequently tested in the community, as lay 
workers visited children at home who did not attend 
facilities for testing as per the protocol procedures.22 
Notably, 20% of children whose index patients initially 
opted for facility-based testing were subsequently tested 
by a community-based approach, but only 5% whose 
index patients opted for community-based testing were 
ultimately tested in a health facility.
The strengths of this study include a large sample size 
and comprehensive ascertainment of outcomes. The 
inclusion criteria were not restricted to biological children 
of index patients to ensure that children who might have 
been orphaned were not excluded. The study was done in 





Univariable analysis Multivariable analysis 
(n=5262)*
aOR (95% CI) p value aOR (95% CI) p value
Index patient variables
Age, years
0–18 29 (1·6%) 1·00 (ref) ·· 1·00 (ref) ··
19–34 480 (26·9%) 1·48 (0·63–3·47) ·· 1·07 (0·46–2·45) ··
35–59 1146 (64·1%) 1·99 (0·86–4·60) ·· 1·27 (0·56–2·89) ··
≥60 132 (7·4%) 2·32 (0·92–5·88) 0·02 1·64 (0·65–4·12) 0.22
Sex
Male 363 (20·3%) 1·00 (ref) ·· ·· ··
Female 1424 (79·7%) 1·00 (0·79–1·27) 0·98 ·· ··
Site
Rural 448 (25·1%) 1·00 (ref) ·· 1·00 (ref) ··
Urban 1339 (74·9%) 2·51 (1·99–3·17) <0·0001 2·29 (1·80–2·91) <0·0001
Highest level of education
None 33 (1·9%) 1·00 (ref) ·· ·· ··
Primary 538 (30·1%) 0·74 (0·33–1·63) 0·45 ·· ··
Secondary 1143 (64·0%) 1·19 (0·54–2·58) 0·67 ·· ··
Tertiary 73 (4·1%) 1·90 (0·76–4·70) 0·17 ·· ··
Mode of transport to facility†
By foot 1003 (56·1%) 1·00 (ref) ·· ·· ··
Public transport 691 (38·7%) 2·42 (1·95–3·00) <0·0001 ·· ··
By car 12 (0·7%) 0·64 (0·25–1·65) 0·35 ·· ··
Other 81 (4·5%) 1·01 (0·60–1·68) 0·98 ·· ··
Cost of travel to facility, US$†
No cost (0 US$) 1090 (61·0%) 1·00 (ref) ·· 1·00 (ref) ··
Some cost (>0 US$) 697 (39·0%) 1·24 (1·18–1·31) <0·0001 1·21 (1·15-1·28) <0·0001
Time since HIV diagnosis, years‡
<1 132 (7·5%) 1·00 (ref) ·· 1·00 (ref) ··
1–5 815 (46·5%) 1·53 (1·07–2·20) ·· 1·58 (1·07–2·31) ··
≥6 804 (45·9%) 1·48 (1·03–2·13) 0·066 1·59 (1·07–2·35) 0·070
Child variables
Sex§
Male 884 (49·5%) 1·00 (ref) ·· ·· ··
Female 902 (50·5%) 0·95 (0·84–1·07) 0·42 ·· ··
Age, years§
2–5 472 (26·4%) 1·00 (ref) ·· 1·00 (ref) ··
6–9 474 (26·5%) 1·26 (1·09–1·47) ·· 1·20 (1·02–1·41) ··
10–15 645 (36·1%) 1·41 (1·21–1·63) ·· 1·35 (1·14–1·59) ··





1028 (57·6%) 1·00 (ref) ·· 1·00 ··
Unknown 758 (42·4%) 1·32 (1·17–1·48) <0·0001 1·33 (1·12–1·59) 0·0013
Relationship to index§
Non-biological child 672 (37·6%) 1·00 (ref) ·· ·· ··
Biological child 1114 (62·4%) 1·09 (0·94–1·26) 0·24 ·· ··
(Table 3 continues on next page)
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making the findings generali sable to similar settings 
within Zimbabwe and the sub-Saharan Africa region. A 
limitation of our app roach, whereby the starting point of 
offering testing is at the facility level, is that it excludes 
index patients who are disengaged from care and whose 
children might be HIV-positive but without a confirmed 
diagnosis. Addi tionally, con tacting participants to ascer tain 
out comes might have indirectly increased uptake. Further-
 more, oral testing results were obtained by self-report. We 
did a substudy to investigate accuracy of care giver testing 
and findings will be reported separ ately. A further limi-
tation was that the study was not aimed or powered to 
investigate index patient factors associated with an 
HIV-positive child diagnosis. If completed, a study foc used 
on index factors associated with HIV-positive child status 
would allow health service providers to further target index-
linked testing in children and adolescents, and we there-
fore recom mend future studies on this aspect.
Evaluation of the affordability of index-linked app-
roaches is crucial to inform scalability. Previous studies 
have shown that community-based HTS stra tegies 
among adults, including HIV self-testing, are cost-effec-
tive compared with facility based HTS in South Africa 
and Malawi.31,32 However, cost-effectiveness of any 
approach will depend on HIV yield and uptake of HTS. A 
cost evaluation of the HTS approaches in the B-GAP 
study is underway and will be reported separately.
Substantial progress has been made in reducing 
the incidence of HIV infection, due to the scale-up of 
PMTCT programmes and improved coverage of ART in 
children. However, implementing strategies to identify 
hard-to-reach groups of children is imperative if the 
UNAIDS 95-95-95 targets (95% of HIV-positive people 
aware of status, ART for 95% of those diagnosed, and viral 
suppression for 95% of those treated by 2030) are to be 
met. Increasing the reach of testing will require strategies 
that target residual barriers to accessing HIV testing, 
which approaches to date have not been able to overcome. 
Although a targeted approach such as index-linked testing 
is an efficient approach in children in whom HIV pre va -
lence is low, coverage to date has not been optimal. Our 
study provides evidence for the effectiveness of com-
munity-based approaches via lay health workers and 
caregivers for the testing of children at risk of HIV. 
Community-based testing might reduce burden on health 
facilities and address barriers to HTS access. Combined 
approaches and providing index patients with choice and 
flexibility might further improve uptake.
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